Pioglitazone Tablet
Product Images NDC 68788-7514

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 68788-7514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)
The text describes a figure in a 26-week study that shows the mean change from baseline for HbAlc in a dose-ranging experiment. The experiment was placebo-controlled and the figure shows the observed values. The X-axis shows the duration of the study in weeks, while the Y-axis shows the mean change from baseline for HbAlc. The figure displays three dosage levels (15mg, 30mg, 45mg) and illustrates how the HbAlc changes from baseline.*
FDA Label Image

Pioglitazone Tablets 30mg (Pioglitazone Fig3)

Pioglitazone Tablets 30mg (Pioglitazone Fig3)
FDA Label Image

Chemical Structure (Pioglitazone Str)

Chemical Structure (Pioglitazone Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.